Skip to main content
. 2019 Apr 26;10:867. doi: 10.3389/fimmu.2019.00867

Table 2.

PD-L1, SEMA4D, and VEGF expressions in ovarian cancer tissues.

Group Cases (N) SEMA4D positive expression N (%) P VEGF positive expression N (%) P PD-L1 positive expression N (%) P
EOC tissues with BC response 63 45 (71.43) 0.017 32 (50.79) 0.030 37 (58.73) 0.033
EOC tissues with BC non-response 61 30 (49.18) 19 (31.15) 24 (39.34)

EOC, epithelial ovarian cancer.

BC, bevacizumab plus single regimen chemotherapy.